Delahaye J P, de Gevigney G
Hôpital Cardiologique, BP Lyon Montchat.
Ann Cardiol Angeiol (Paris). 1994 Dec;43(10):578-87.
Cardiologists and heart surgeons are often faced with the problem of the optimal therapeutic indication in patients with valvular heart disease presenting with severe myocardial dysfunction, as it is difficult to evaluate the degree of reversibility of a severe alteration of ventricular function in these patients. Myocardial dysfunction is often multifactorial in patients with valvular heart disease and the role of myocardial ischaemia secondary to associated coronary heart disease must not be neglected. On the other hand, the compensatory capacity of the myocardium varies from one patient to another ("constitutional" myocardial factor or related to the aetiology of the valvular heart disease?). Although the methods of investigation of myocardial function currently available are able to precisely evaluate the degree of severity of myocardial dysfunction, they are unable to accurately predict the degree of reversibility. 1. In pure mitral stenosis, severe left ventricular dysfunction is very rare; more or less rapidly, pulmonary hypertension induces slowly progressive right ventricular dysfunction which remains reversible for a long time. 2. In mitral incompetence, left ventricular systolic function is correctly evaluated by the ejection fraction (LVEF). There is a high risk of irreversible left ventricular dysfunction in operated patients with an LVEF of less than 0.40. In these patients, left ventricular function is slightly improved after mitral repair, while LVEF decreases after mitral valve replacement. The combined study of right ventricular systolic function is useful in patients with mitral disease, as this function may be insidiously altered and the presence of right heart failure, regardless of its cause, considerably increases the late postoperative mortality of mitral valve disease. 3. In aortic stenosis, left ventricular dysfunction, hypertrophy and interstitial fibrosis remain reversible for a long time. Severe alteration of LV function therefore does not exclude the possibility of very good postoperative recovery. However, this is improbable in the presence of: a very marked increase in LV mass and/or end-systolic volume, and/or inoperable associated coronary artery disease, and/or the combination of low ejection fraction, severely decreased cardiac output, and low transvalvular gradient (not increased by cautious dobutamine infusion), and/or clinical signs of complete heart failure. 4. In aortic incompetence, progressive alteration of left ventricular function, often asymptomatic, is reflected by the increased dimensions of the LV and a reduction of the fraction of ejection. The reversibility of LV dysfunction is difficult for evaluate. The long clinical course of this dysfunction is one of the most reliable predictors of irreversibility, together with a fall in the resting isotope LVEF.(ABSTRACT TRUNCATED AT 250 WORDS)
心脏病专家和心脏外科医生常常面临一个问题,即对于患有严重心肌功能障碍的瓣膜性心脏病患者,如何确定最佳治疗指征,因为很难评估这些患者心室功能严重改变的可逆程度。在瓣膜性心脏病患者中,心肌功能障碍往往是多因素导致的,继发于相关冠心病的心肌缺血的作用不可忽视。另一方面,心肌的代偿能力因患者而异(“体质性”心肌因素还是与瓣膜性心脏病的病因有关?)。虽然目前可用的心肌功能检查方法能够精确评估心肌功能障碍的严重程度,但它们无法准确预测可逆程度。1. 在单纯二尖瓣狭窄中,严重左心室功能障碍非常罕见;肺动脉高压或多或少会迅速导致缓慢进展的右心室功能障碍,且这种障碍在很长一段时间内仍可逆转。2. 在二尖瓣关闭不全中,左心室收缩功能可通过射血分数(LVEF)正确评估。LVEF小于0.40的手术患者发生不可逆左心室功能障碍的风险很高。在这些患者中,二尖瓣修复后左心室功能略有改善,而二尖瓣置换后LVEF会降低。对右心室收缩功能进行联合研究对二尖瓣疾病患者很有用,因为这种功能可能会不知不觉地发生改变,而且无论病因如何,右心衰竭的存在都会显著增加二尖瓣疾病患者术后晚期死亡率。3. 在主动脉瓣狭窄中,左心室功能障碍、肥厚和间质纤维化在很长一段时间内仍可逆转。因此,左心室功能的严重改变并不排除术后恢复良好的可能性。然而,在以下情况下这种可能性不大:左心室质量和/或收缩末期容积显著增加,和/或存在无法手术的相关冠状动脉疾病,和/或射血分数低、心输出量严重降低和跨瓣膜压差低(谨慎输注多巴酚丁胺后未增加),和/或存在完全心力衰竭的临床体征。4. 在主动脉瓣关闭不全中,左心室功能的逐渐改变通常无症状,表现为左心室尺寸增加和射血分数降低。左心室功能障碍的可逆性很难评估。这种功能障碍的漫长临床病程是不可逆性最可靠的预测指标之一,静息同位素LVEF下降也是如此。(摘要截选至250字)